Specialty Pharmacy Pays $17 Million To Settle Whistleblower Lawsuit Alleging Medicare Billing Fraud. Exposing Misconduct.

Specialty Pharmacy Pays $17 Million To Settle Whistleblower Lawsuit Alleging Medicare Billing Fraud

February 4, 2019

RADNOR, Pa.Feb. 4, 2019 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP (“Kessler Topaz”) announced today that Pentec Health Inc. (“Pentec”), a nationwide specialty pharmacy, has agreed to settle a whistleblower lawsuit and pay the United States government $17 million.  Kessler Topaz represented the whistleblower, Jean Brasher, and filed the qui tam lawsuit in 2013.

The settlement resolves allegations that Pentec induced prescriptions and use of Proplete, an expensive drug compounded and sold by Pentec, by illegally waiving amounts owed by Medicare beneficiaries.  In addition, Pentec was alleged to have overbilled Medicare for excess drug ingredients.

“We believe that this case reaffirms the role that whistleblowers can play in combatting fraud.  Compounding pharmacies cannot promote expensive drugs through illegal means or overbill Medicare for excess ingredients, as this complaint alleges,” said David Bocian, a former federal prosecutor and head of Kessler Topaz’s Whistleblower and False Claims Act Litigation practice group.  Bocian thanked the U.S. Attorney’s Office in Philadelphia for their outstanding work on and dedication to the case.

Read more here.
The materials on this website are for general information purposes only and should not be construed as legal advice, legal opinion or any other advice on any specific facts or circumstances. Readers should not act or refrain from acting upon this information without seeking professional advice. Transmission of information on or by use of this website is not intended to create, and receipt does not constitute, a lawyer-client relationship between the sender and receiver.
Mobile Menu